Cargando…
SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens
The quality of an antigen-specific CD8(+) T cell repertoire is crucial for the clearance of intracellular pathogens, in particular for viral infections. Here, we describe killing assays to determine the function of CD8(+) T cells engineered with SARS-CoV-2-specific T cell receptors in a near-physiol...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411149/ https://www.ncbi.nlm.nih.gov/pubmed/36152303 http://dx.doi.org/10.1016/j.xpro.2022.101699 |
_version_ | 1784775255216095232 |
---|---|
author | Mateyka, Laura M. Grass, Vincent Pichlmair, Andreas Busch, Dirk H. D’Ippolito, Elvira |
author_facet | Mateyka, Laura M. Grass, Vincent Pichlmair, Andreas Busch, Dirk H. D’Ippolito, Elvira |
author_sort | Mateyka, Laura M. |
collection | PubMed |
description | The quality of an antigen-specific CD8(+) T cell repertoire is crucial for the clearance of intracellular pathogens, in particular for viral infections. Here, we describe killing assays to determine the function of CD8(+) T cells engineered with SARS-CoV-2-specific T cell receptors in a near-physiological system for antigen presentation. We detail the use of target cells either infected with replicating SARS-CoV-2 virus or engineered with SARS-CoV-2 open reading frames. For complete details on the use and execution of this protocol, please refer to Moosmann et al. (2022) and Wagner et al. (2022). |
format | Online Article Text |
id | pubmed-9411149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94111492022-08-26 SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens Mateyka, Laura M. Grass, Vincent Pichlmair, Andreas Busch, Dirk H. D’Ippolito, Elvira STAR Protoc Protocol The quality of an antigen-specific CD8(+) T cell repertoire is crucial for the clearance of intracellular pathogens, in particular for viral infections. Here, we describe killing assays to determine the function of CD8(+) T cells engineered with SARS-CoV-2-specific T cell receptors in a near-physiological system for antigen presentation. We detail the use of target cells either infected with replicating SARS-CoV-2 virus or engineered with SARS-CoV-2 open reading frames. For complete details on the use and execution of this protocol, please refer to Moosmann et al. (2022) and Wagner et al. (2022). Elsevier 2022-08-26 /pmc/articles/PMC9411149/ /pubmed/36152303 http://dx.doi.org/10.1016/j.xpro.2022.101699 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Protocol Mateyka, Laura M. Grass, Vincent Pichlmair, Andreas Busch, Dirk H. D’Ippolito, Elvira SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens |
title | SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens |
title_full | SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens |
title_fullStr | SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens |
title_full_unstemmed | SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens |
title_short | SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens |
title_sort | sars-cov-2 cd8(+) t cell killing assays using replicating viruses and transgenic antigens |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411149/ https://www.ncbi.nlm.nih.gov/pubmed/36152303 http://dx.doi.org/10.1016/j.xpro.2022.101699 |
work_keys_str_mv | AT mateykalauram sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens AT grassvincent sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens AT pichlmairandreas sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens AT buschdirkh sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens AT dippolitoelvira sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens |